KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Castle Biosciences (CSTL) Income from Continuing Operations (2018 - 2026)

Castle Biosciences' Income from Continuing Operations history spans 8 years, with the latest figure at 2332000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 124.32% to 2332000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 24158000.0, a 232.41% decrease, with the full-year FY2025 number at 24158000.0, down 232.41% from a year prior.
  • Income from Continuing Operations hit 2332000.0 in Q4 2025 for Castle Biosciences, down from 501000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for CSTL hit a ceiling of 9590000.0 in Q4 2024 and a floor of 29204000.0 in Q1 2023.
  • Historically, Income from Continuing Operations has averaged 8438000.0 across 5 years, with a median of 5592500.0 in 2021.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 1039.38% in 2023 and later surged 471.71% in 2024.
  • Tracing CSTL's Income from Continuing Operations over 5 years: stood at 13381000.0 in 2021, then tumbled by 54.08% to 20618000.0 in 2022, then soared by 87.49% to 2580000.0 in 2023, then surged by 471.71% to 9590000.0 in 2024, then plummeted by 124.32% to 2332000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CSTL at 2332000.0 in Q4 2025, 501000.0 in Q3 2025, and 4523000.0 in Q2 2025.